CRAIGAVON, Northern Ireland--(BUSINESS WIRE)--Almac announces the launch of its revolutionary new forecasting platform, COMPASS, which has been specifically designed to improve the accuracy and ...
Almac Group has today announced a $48 million investment in eClinical technologies that includes the launch of Almac Trial Coordinator™ – a first-in-class interoperable clinical trial technology ...
“Experience through zealous research” is part of the DNA of the 50-year-old Almac Group. That philosophy spurs the Almac Group to continuously build out its capabilities, including acquiring, in 2004, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results